Plasmic activity of phospholipid membranes in nephritis


Cite item

Full Text

Abstract

Aim. To study activity of plasmic phospholipid membranes (PPM) in patients with chronic nephritis (CN) as regards clinical-laboratory and morphological characteristics of the disease. Material and methods. 10 patients with chronic mesangial glomerulonephritis (CMG) and 4 patients with chronic drug-induced tubulointerstitial nephritis were examined. All the patients had moderate arterial hypertension including 5 patients with CMG combined with nephrotic syndrome. 9 patients had elevated blood creatinine (up to 500 mcmol/l). Measurements were made of routine laboratory indices, blood coagulation andparacoagulation, Willebrand's factor (WF), aggregation time (AT), phospholipid activation of blood coagulation (FABC), morphological indices of activity and sclerosis. Results. In spite of chronic latent intravascular blood coagulation, CN was characterized by apparent lowering of FABC which was more evident in CMG. There was a weak correlation between a FABC fall and the level of proteinuria, lipidemia, AT of platelets, indices of activity. Some parallels exist between creatininemia and activity of PPM. A close reverse relationship was found between FABC and WF, and a direct one between FABC and sclerosis index.
Conclusion. Subnormal PPM activity in CN correlates with organic microthrombi formation and promotes the discussion of both mechanisms of FABC formation disturbances and possible ways of PPM consumption including enhanced diffusion into the mesangium in progressing nephrosclerosis.

References

  1. Зубаиров Д. М. Биохимия свертывания крови. М.: Медицина; 1978.
  2. Barcagan Z. S., Momot A. P., Bishevsky К. М. The role of coagulation in the pathogenesis of different forms of DlC-syndrome. In: XXXV Hamburger symposiun viber Blutgerinnung. Hamburg; 1992. 239-240.
  3. Баркаган 3. С., Момот А. П. Основные методы лабораторной диагнотики нарушений системы гемостаза: Метод. рекомендации. Барнаул; 1998.
  4. Barnes J. L. Platelets in glomerular disease. Nephron 1997; 77: 378-393.
  5. Rabelink T. J., Zwaginga J. J., Koomans M. A., Sixma J. J. Thrombosis and hemostasis in renal disease. Kidney Int. 1994; 46: 287-296.
  6. Лоскутова С. А. Фосфолипидная активация свертывания крови и липидный спектр плазмы при липоидном нефрозе: Автореф. дис. ... канд. мед. наук. Новосибирск, 1999.
  7. Тареева И. Е., Кушырина И. М., Неверов Н. И. Пути торможения неиммунного прогрессирования нефритов. Клин. мед. 1995: 3: 80-83.
  8. Sakemi Т., Ваbа N. Effects of an angiotensin II receptor antagonist on the progression of renal failure in hyperlipidemic Imai rats. Nephron 1993; 65 (3): 426-432.
  9. Папаян Л. П. Новые данные о метаболизме, физиологической функции фактора Виллебранда и его роли в патологии гемостаза. Биохимия животных и человека 1991; 15: 39-48.
  10. Климов А. Н., Никульчева Н. Г. Липиды, липопротеиды и атеросклероз. СПб; 1995.
  11. Титов В. Н. Патогенез атеросклероза для XXI века. Клин. лаб. диагн. 1998; 4: 3-13.
  12. Avram M. M. Low-density lipoprotein immunofluorescence at side of renal injury in glomerulosclerosis: a potential pathogenetic role for lipids in renal disease. Am. J. Kidney Dis. 1993; 22 (1): 69-71.
  13. Kasiske B. L., O'Donnell M. P., Cowardin W., Keane W. F. Lipids and the kidney. Hypertension 1990; 15 (5); 443-450.
  14. Fernando R. L., Varghere Z, Moorhead J. F. Oxidation of lowdensity lipoproteins by rat mesangial cells and the interaction of oxidized low-density lipoproteins with rat mesangial cell in vitro. Nephrol. Dial. Transplant. 1993; 8 (6): 512-518.
  15. Kees-Folts D., Diamond J. R. Relationship between hyperlipidemia, lipid mediators and progressive glomerulosclerosis in the nephrotic syndrome. Am. J. Nephrol. 1993; 13 (5): 365- 375-
  16. Wheeler D. C. Lipids (what is the evidence for their role in progressive renal disease?). Nephrol. Dial. Transplant. 1995; 10 (1); 443-450.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2003 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

© 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies